These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23639619)

  • 1. Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.
    Field KM; Drummond KJ; Yilmaz M; Tacey M; Compston D; Gibbs P; Rosenthal MA
    J Clin Neurosci; 2013 Jun; 20(6):783-9. PubMed ID: 23639619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of enrollment in clinical trials on survival of patients with glioblastoma.
    Shahar T; Nossek E; Steinberg DM; Rozovski U; Blumenthal DT; Bokstein F; Sitt R; Freedman S; Corn BW; Kanner AA; Ram Z
    J Clin Neurosci; 2012 Nov; 19(11):1530-4. PubMed ID: 22989795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and prognostic factors in adult cerebellar glioblastoma.
    Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
    J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving prognosis of glioblastoma in the 21st century: who has benefited most?
    Lawrence YR; Mishra MV; Werner-Wasik M; Andrews DW; Showalter TN; Glass J; Shen X; Symon Z; Dicker AP
    Cancer; 2012 Sep; 118(17):4228-34. PubMed ID: 22180310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
    Wang XW; Boisselier B; Rossetto M; Marie Y; Idbaih A; Mokhtari K; Gousias K; Hoang-Xuan K; Delattre JY; Simon M; Labussière M; Sanson M
    Cancer; 2013 Feb; 119(4):806-13. PubMed ID: 23184331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waiting time to radiotherapy as a prognostic factor for glioblastoma patients in a scenario of medical disparities.
    Loureiro LV; Pontes Lde B; Callegaro-Filho D; Koch Lde O; Weltman E; Victor Eda S; Santos AJ; Borges LR; Segreto RA; Malheiros SM
    Arq Neuropsiquiatr; 2015 Feb; 73(2):104-10. PubMed ID: 25742578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset.
    Field KM; Rosenthal MA; Yilmaz M; Tacey M; Drummond K
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):153-61. PubMed ID: 23701649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China.
    Ma X; Lv Y; Liu J; Wang D; Huang Q; Wang X; Li G; Xu S; Li X
    J Clin Neurosci; 2009 Dec; 16(12):1595-8. PubMed ID: 19793663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.
    Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S
    Oncology; 2012; 83(1):1-9. PubMed ID: 22688083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.
    Gorlia T; Stupp R; Brandes AA; Rampling RR; Fumoleau P; Dittrich C; Campone MM; Twelves CC; Raymond E; Hegi ME; Lacombe D; van den Bent MJ
    Eur J Cancer; 2012 May; 48(8):1176-84. PubMed ID: 22464345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrollment in clinical trials correlates with improved survival in metastatic melanoma.
    Seetharamu N; Tu TJ; Christos P; Ott PA; Berman RS; Shapiro RL; Osman I; Pavlick AC
    Oncology; 2011; 81(5-6):403-9. PubMed ID: 22270052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of seizure in patients with glioblastoma multiforme.
    Ozbek N; Cakir S; Gursel B; Meydan D
    Neurol India; 2004 Mar; 52(1):76-8. PubMed ID: 15069244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
    De Vleeschouwer S; Fieuws S; Rutkowski S; Van Calenbergh F; Van Loon J; Goffin J; Sciot R; Wilms G; Demaerel P; Warmuth-Metz M; Soerensen N; Wolff JE; Wagner S; Kaempgen E; Van Gool SW
    Clin Cancer Res; 2008 May; 14(10):3098-104. PubMed ID: 18483377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma multiforme: a review of where we have been and where we are going.
    Adamson C; Kanu OO; Mehta AI; Di C; Lin N; Mattox AK; Bigner DD
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1061-83. PubMed ID: 19555299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.
    Tait MJ; Petrik V; Loosemore A; Bell BA; Papadopoulos MC
    Br J Neurosurg; 2007 Oct; 21(5):496-500. PubMed ID: 17852105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome of elderly patients with glioblastoma who received combination therapy.
    Shikama N; Sasaki S; Shinoda A; Koiwai K
    Am J Clin Oncol; 2012 Oct; 35(5):486-9. PubMed ID: 21606821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma multiforme-report of 267 cases treated at a single institution.
    Stark AM; Nabavi A; Mehdorn HM; Blömer U
    Surg Neurol; 2005 Feb; 63(2):162-9; discussion 169. PubMed ID: 15680662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme.
    Hsieh PC; Chandler JP; Bhangoo S; Panagiotopoulos K; Kalapurakal JA; Marymont MH; Cozzens JW; Levy RM; Salehi S
    Neurosurgery; 2005 Oct; 57(4):684-92; discussion 684-92. PubMed ID: 16239880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.